不明原因出血性疾病女性的妊娠结局与管理
该回顾性病例记录审查纳入英国四家血友病综合关怀中心2010至2020年间36例不明原因出血性疾病(BDUC)患者的60次分娩,中位出血评估工具评分为9分。无初级止血预防者产后出血(PPH)的比值比为6.3(95%CI 1.2-34.2,P<.05),预防组PPH发生率为16/45(36%),未预防组为7/9(78%)。尽管进行了止血预防,PPH仍常见,需进一步前瞻性研究确定妊娠期最佳管理及出血的病理生理基础。
要点
- BDUC患者妊娠期PPH风险高,未行初级止血预防者PPH风险约为预防者的6.3倍。
- 止血预防使用氨甲环酸,部分患者接受去氨加压素或血小板输注。
- 继发性PPH发生率为5/60(8%),未观察到新生儿出血或母体血栓栓塞并发症。
核心结论
- 尽管进行了止血预防,BDUC患者妊娠期产后出血仍常见。
- 需要进一步前瞻性研究来确定BDUC患者妊娠期的最佳管理以及出血的病理生理基础。
研究设计与样本
- 回顾性病例记录审查,来自英国四家血友病综合关怀中心,时间范围为2010至2020年。
- 共记录了36例患者的60次分娩。
主要发现
- 中位国际血栓与止血学会出血评估工具评分为9分。
- 在54例有数据的病例中,无初级止血预防者产后出血的比值比为6.3(95%CI 1.2-34.2,P<.05),未预防组PPH发生率为7/9(78%),预防组为16/45(36%)。
- 继发性产后出血发生于5/60(8%)的病例。
- 未观察到新生儿出血并发症或母体血栓栓塞并发症。
临床怎么用
- 止血预防使用氨甲环酸,部分患者接受去氨加压素或血小板输注。
- 常建议避免区域麻醉并采取胎儿分娩预防措施,但在少数发生这些情况的患者中未观察到并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with a bleeding tendency with normal laboratory tests have been described as having an unclassified bleeding disorder or bleeding disorder of unknown cause (BDUC). There are very little data available on how to manage pregnancy. OBJECTIVES: To study management and outcomes of these patients at four United Kingdom hemophilia comprehensive care centers. METHODS: Retrospective case note review from 2010-2020. RESULTS: Sixty deliveries in 36 patients were recorded. The median International Society on Thrombosis and Haemostasis bleeding assessment tool score was 9. In 54 cases for which data were available, the odds ratio for post partum hemorrhage (PPH) was 6.3 for no primary hemostatic prophylaxis versus prophylaxis (95% confidence interval 1.2-34.2, p < .05); 7/9 (78%) versus 16/45 (36%) PPH incidence for the groups, respectively. Hemostatic prophylaxis was with tranexamic acid but some patients received desmopressin or platelet infusions. Secondary PPH was seen in 5/60 (8%) of cases. No neonatal bleeding complications or maternal thromboembolic complications were noted. Avoidance of regional anesthesia and fetal delivery precautions were commonly advised, but in the small number of cases in which they occurred no complications were noted. CONCLUSIONS: Despite hemostatic prophylaxis PPH was commonly seen. Further prospective studies of BDUC patients are required to determine optimal management in pregnancy as well as determine the pathophysiological basis of bleeding.
引用
- Castle D, Desborough MJR, Kemp M, et al. Outcomes and management of pregnancy in women with bleeding disorder of unknown cause. J Thromb Haemost. 2022. PMID: 36053176. doi:10.1111/jth.15871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。